The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Secondary Amenorrhea After Hodgkin’s Lymphoma Is Influenced by Age at Treatment, Stage of Disease, Chemotherapy Regimen, and the Use of Oral Contraceptives During Therapy: A Report From the German Hodgkin’s Lymphoma Study Group
Abstract
Purpose: Long-term survivors of successfully treated Hodgkin’s lymphoma (HL) are at risk for late complications. Among these, infertility for female patients is of major importance. The subject of this analysis is to evaluate the menstrual status after HL therapy. Patients and Methods: From 1994 to 1998, the German Hodgkin’s Lymphoma Study Group conducted clinical trials for early-, intermediate-, and advanced-stage HL (trials HD7 to HD9) involving a total of 3,186 patients. A survey was carried out to evaluate the menstrual status after therapy. The following factors were assessed concerning their influence on amenorrhea: age, treatment, stage, and the use of oral contraceptives during chemotherapy. Results: A total of 405 women aged younger than 40 years answered the study questions. After a median follow-up of 3.2 years, 51.4% of the women receiving eight cycles of dose-escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) had continuous amenorrhea. Amenorrhea was significantly more frequent after dose-escalated BEACOPP compared with doxorubicin, bleomycin, vinblastine, and dacarbazine; cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, vinblastine, and dacarbazine; or standard BEACOPP (P = .0066). Amenorrhea after therapy was most pronounced in women with advanced-stage HL (P < .0001), in women older than 30 years at treatment (P = .0065), and in women who did not take oral contraceptives during chemotherapy (P = .0002). Conclusion: Most women who are treated for advanced-stage HL experience amenorrhea after therapy. Amenorrhea is significantly more frequent in women with advanced-stage HL receiving eight cycles of dose-escalated BEACOPP and in women older than 30 years at first treatment. Furthermore, the data show a statistical association between the use of oral contraceptives and return of menstrual cycle, which is subject to further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
Donnez, J., Dolmans, M., Demylle, D., Jadoul, P., Pirard, C., Squifflet, J., Martinez-Madrid, B., & Van Langendonckt, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17222-x · Cited by 1,631
Diehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., Tesch, H., Herrmann, R., Dörken, B., Müller-Hermelink, H.-K., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022473 · Cited by 838
Self-citationOvarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.
Bines, J., Oleske, D. M., & Cobleigh, M. A. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1718 · Cited by 816
Hull, M. C. (2003) · JAMA · doi:10.1001/jama.290.21.2831 · Cited by 644
Bhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., DeLaat, C., Fossati-Bellani, F., Morgan, E., Oberlin, O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.059 · Cited by 613
Lung Cancer Following Chemotherapy and Radiotherapy for Hodgkin's Disease
Travis, L. B. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.3.182 · Cited by 562
Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., & Linch, D. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.498 · Cited by 476
Engert, A., Schiller, P., Josting, A., Herrmann, R., Koch, P., Sieber, M., Boissevain, F., de Wit, M., Mezger, J., Dühmke, E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.023 · Cited by 460
Self-citationEarly menopause in long-term survivors of cancer during adolescence
Byrne, J., Fears, T. R., Gail, M. H., Pee, D., Connelly, R. R., Austin, D. F., Holmes, G. F., Holmes, F. F., Latourette, H. B., Meigs, J. W., et al. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91335-8 · Cited by 439
van Leeuwen, F. E., Klokman, W. J., Veer, M. B. V., Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.3.487 · Cited by 436
van Leeuwen, F. E., Klokman, W. J., Stovall, M., Dahler, E. C., van't Veer, M. B., Noordijk, E. M., Crommelin, M. A., Aleman, B. M. P., Broeks, A., Gospodarowicz, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.971 · Cited by 402
Shaw, J. M., Bowles, J., Koopman, P., Wood, E. C., & Trounson, A. O. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019467 · Cited by 301
The effect of combination chemotherapy on ovarian function in women treated for hodgkin's disease
Whitehead, E., Shalet, S. M., Blackledge, G., Todd, I., Crowther, D., & Beardwell, C. G. (1983) · Cancer · doi:10.1002/1097-0142(19830915)52:6<988::aid-cncr2820520610>3.0.co;2-6 · Cited by 241
Schilsky, R. L., Sherins, R. J., Hubbard, S. M., Wesley, M. N., Young, R. C., & DeVita, V. T. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90205-9 · Cited by 199
Human ovarian tissue cryopreservation: indications and feasibility
Poirot, C., Vacher-Lavenu, M.-C., Helardot, P., Guibert, J., Brugières, L., & Jouannet, P. (2002) · Human Reproduction · doi:10.1093/humrep/17.6.1447 · Cited by 198
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients
Goldhirsch, A., Gelber, R. D., & Castiglione, M. (1990) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a057718 · Cited by 196
Chapman, R., & Sutcliffe, S. (1981) · Blood · doi:10.1182/blood.v58.4.849.849 · Cited by 188
Josting, A., Wiedenmann, S., Franklin, J., May, M., Sieber, M., Wolf, J., Engert, A., & Diehl, V. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.160 · Cited by 161
Self-citationFertility after treatment for Hodgkin's disease
Blumenfeld, Z., Dann, E. J., Avivi, I. M., Epelbaum, R., & Rowe, J. M. (2002) · Annals of Oncology · doi:10.1093/annonc/13.s1.138 · Cited by 151
Infertility and premature menopause in childhood cancer survivors
Byrne, J. (1999) · Medical and Pediatric Oncology · Cited by 85
Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy
Kapusta, L., Loonen, J. J., THIJSSEN, J. M., deGraaf, R., & Daniëls, O. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10383 · Cited by 38
Holada, K., Šimák, J., Risitano, A. M., Maciejewski, J. P., Young, N. S., & Vostal, J. G. (2002) · Blood · doi:10.1182/blood.v100.1.341 · Cited by 37
Cited by
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., Beck, L. N., Brennan, L. V., & Oktay, K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5888 · Cited by 2,048
Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma
Ansell, S. M., Radford, J., Connors, J. M., Długosz-Danecka, M., Kim, W.-S., Gallamini, A., Ramchandren, R., Friedberg, J. W., Advani, R., Hutchings, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206125 · Cited by 347
Fertility Preservation in Adolescents and Young Adults With Cancer
Levine, J., Canada, A., & Stern, C. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8312 · Cited by 323
Santarsieri, A., Mitchell, E., Pham, M. H., Sanghvi, R., Jablonski, J., Lee-Six, H., Sturgess, K., Brice, P., Menne, T. F., Osborne, W., et al. (2025) · The Lancet Oncology · doi:10.1016/s1470-2045(24)00598-9 · Cited by 12
Metadata
- Authors
- Behringer, K., Breuer, K., Reineke, T., May, M., Nogova, L., Klimm, B., Schmitz, T., Wildt, L., Diehl, V., & Engert, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-10-20
- Volume
- 23
- Issue
- 30
- Pages
- 7555-7564
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1976281058
- Cited by
- 296
- References
- 22
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.